NO974400L - Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan - Google Patents

Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Info

Publication number
NO974400L
NO974400L NO974400A NO974400A NO974400L NO 974400 L NO974400 L NO 974400L NO 974400 A NO974400 A NO 974400A NO 974400 A NO974400 A NO 974400A NO 974400 L NO974400 L NO 974400L
Authority
NO
Norway
Prior art keywords
benazeprilat
valsartan
formula
preparations containing
combination preparations
Prior art date
Application number
NO974400A
Other languages
English (en)
Norwegian (no)
Other versions
NO974400D0 (no
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO974400D0 publication Critical patent/NO974400D0/no
Publication of NO974400L publication Critical patent/NO974400L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO974400A 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan NO974400L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (2)

Publication Number Publication Date
NO974400D0 NO974400D0 (no) 1997-09-23
NO974400L true NO974400L (no) 1997-09-23

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974400A NO974400L (no) 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (cs)
JP (1) JPH11503139A (cs)
KR (1) KR19980703647A (cs)
CN (1) CN1181019A (cs)
AU (1) AU5399096A (cs)
BR (1) BR9604818A (cs)
CA (1) CA2214143A1 (cs)
CZ (1) CZ313897A3 (cs)
HU (1) HUP9801593A2 (cs)
MX (1) MX9707683A (cs)
NO (1) NO974400L (cs)
PL (1) PL322529A1 (cs)
SK (1) SK133897A3 (cs)
TR (1) TR199701121T1 (cs)
WO (1) WO1996031234A1 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508894A (ja) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
CN1440283A (zh) * 2000-04-12 2003-09-03 诺瓦提斯公司 有机化合物的联合形式
AR032758A1 (es) 2000-07-19 2003-11-26 Novartis Ag Sales valsartan, un proceso para su fabricacion, composiciones farmaceuticas y el uso de dichas sales para la preparacion de medicamentos
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
HRP20030124A2 (en) * 2000-08-22 2005-02-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
HUP0302455A3 (en) * 2000-12-18 2005-05-30 Novartis Ag Combination pharmaceutical compositions containing amplodipine and benazepril and their use
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
US20050272649A1 (en) * 2002-08-28 2005-12-08 Hruska Keith A Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
EP2432452B1 (de) 2009-05-20 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische telmisartan-trinklösung
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
AU2015210898A1 (en) * 2014-01-31 2016-07-28 Janssen Pharmaceutica Nv Methods for the treatment and prevention of renal disorders and fatty liver disorders
KR20220054292A (ko) 2019-07-09 2022-05-02 베링거잉겔하임베트메디카게엠베하 개의 고혈압 치료를 위한 텔미사르탄

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0527879T3 (da) * 1990-05-11 1997-07-14 Pfizer Synergistiske terapeutiske præparater og fremgangsmåder.
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
TR199701121T1 (xx) 1998-03-21
MX9707683A (es) 1997-12-31
AU5399096A (en) 1996-10-23
HUP9801593A2 (hu) 1999-01-28
WO1996031234A1 (en) 1996-10-10
JPH11503139A (ja) 1999-03-23
CZ313897A3 (cs) 1998-01-14
BR9604818A (pt) 1998-06-09
PL322529A1 (en) 1998-02-02
CA2214143A1 (en) 1996-10-10
CN1181019A (zh) 1998-05-06
SK133897A3 (en) 1998-02-04
NO974400D0 (no) 1997-09-23
EP0820302A1 (en) 1998-01-28
KR19980703647A (ko) 1998-12-05

Similar Documents

Publication Publication Date Title
NO974400L (no) Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
GB9914486D0 (en) Medicaments
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
CA2216796A1 (en) Quinazoline derivatives
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
WO1996016981A3 (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AU3664401A (en) Platelet adp receptor inhibitors
RU94044677A (ru) Трехзамещенные фенильные производные, способ получения, фармацевтическая композиция
ATE202337T1 (de) Cyclopropylalkansäurederivate
DE69530081D1 (de) Gastrin- und cck-antagonisten
DE69425162D1 (de) 4,5-diaryloxazol-derivate
WO1999026932A8 (en) By amidino group substituted heterocyclic derivatives and their use as anticoagulants
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
MX9704856A (es) Derivados de indazol sustituidos.
NO20001514L (no) Vitronectin-reseptor-antagonist
FI973691A7 (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäv iä koostumuksia